MedTrace Logo

Ability of Beta-glucan Supplementation to Augment Immune Function

NCT03769012 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-02-03

No results posted yet for this study

Summary

This proposed study is designed to assess the efficacy of a capsule containing beta-glucan taken orally daily as compared to a placebo capsule on the URTI symptoms, and the immune response change in marathon runners

Conditions

  • Cold
  • Cold Symptom
  • Flu
  • Flu Symptom
  • Supplement
  • Stress
  • Gastrointestinal Tolerance

Interventions

DIETARY_SUPPLEMENT

Beta-Glucan

95% beta-glucan sourced from whole cell Euglena Gracilis

DIETARY_SUPPLEMENT

Placebo

microcrystalline cellulose

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Kemin Foods LC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-27
Primary Completion
2019-11-30
Completion
2020-05-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03769012 on ClinicalTrials.gov